Mineral trioxide aggregate induces the release of matrix metalloproteinase-9 by human neutrophils  by Lee, Ya-Yun et al.
Journal of Dental Sciences (2013) 8, 378e384Available online at www.sciencedirect.com
journal homepage: www.e- jds.comORIGINAL ARTICLEMineral trioxide aggregate induces the
release of matrix metalloproteinase-9 by
human neutrophilsYa-Yun Lee a, Yu-Chung Li a, Shan-Ling Hung a,b, Yi-Chen Chen c,
Yuan-Ho Lee d, Shue-Fen Yang b,c*a Institute of Oral Biology, National Yang-Ming University, Taipei, Taiwan
bDepartment of Dentistry, National Yang-Ming University, Taipei, Taiwan
cDepartment of Stomatology, Taipei Veterans General Hospital, Taipei, Taiwan
dDepartment of Economics, Fo-Guang University, Yilan, TaiwanReceived 23 March 2012; Final revision received 19 December 2012
Available online 22 March 2013KEYWORDS
cytotoxicity;
matrix
metalloproteinase-9;
mineral trioxide
aggregate;
neutrophils* Corresponding author. Departmen
Taiwan.
E-mail address: sfyang@vghtpe.go
1991-7902/$36 Copyrightª 2013, Assoc
http://dx.doi.org/10.1016/j.jds.2012.1Abstract Background/purpose: As a pulp capping agent, mineral trioxide aggregate (MTA) is
commonly applied on inflamed tissues that present with a variety of immunocompetent cells,
including neutrophils. Neutrophils are a major source of matrix metalloproteinases (MMPs) that
have been implicated in the process of dentinogenesis. This study aimed to investigate the
impact of MTA on human neutrophils.
Materials and methods: Freshly purified human neutrophils were incubated with MTA or
another commonly used filling material, intermediate restorative material (IRM). The viability
and phagocytic activity of treated neutrophils were assessed by flow cytometry. In addition,
the morphology of neutrophils was observed under scanning electron microscopy and the pro-
duction of MMP-9 was analyzed by gelatin gel zymography.
Results: Treatment with MTA did not affect the viability, morphology, and phagocytic activity
of neutrophils significantly. However, MTA increased the production of MMP-9 in neutrophils.
However, IRM reduced the viability and altered cell morphology of the neutrophils.
Conclusion: MTA may participate in the pulpal inflammatory response by increasing MMP-9 pro-
duction of neutrophils. These signals may facilitate the repair of dental pulp tissue.
Copyright ª 2013, Association for Dental Sciences of the Republic of China. Published by Else-
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v.tw (S.-F. Yang).
iation for Dental Sciences of the Republic of China. Published by Elsevier Taiwan LLC. All rights reserved.
2.010
Effects of MTA on human neutrophils 379Introduction
material (IRM, Dentsply Caulk, Milford, DE, USA), was usedDental caries is by far the most common external stimulus of
dental pulp. As dental pulp possesses certain capacities to
defend and repair itself from injuries, current trends in pulpal
treatment aim at maintaining pulpal vitality to a greater
extent.1,2 Mineral trioxide aggregate (MTA) has recently been
recommended for use in vital pulp treatment due to its ability
to seal the canal space and induce hard-tissue formation.1e5
Histological findings have revealed that when MTA was used
for vital pulp procedures, healing or bridge formation was
observedat thepulp-exposure interface.6 Itwas reported that
MTA is associatedwithdentinogenesis through the inductionof
odontoblastic differentiation of human dental pulp stem cells
via mitogen-activated protein kinase signaling pathways.7
In response to dental caries, neutrophils are the first
immune cells recruited to the lesion site to defend against
invading pathogens. It has been demonstrated that neu-
trophils can be detected in the dental pulp when a carious
lesion is about 2e3 mm from the pulp chamber, and the
number of neutrophils markedly increases when the depth
of the lesion extends to only 0.5 mm from the pulp.8 Neu-
trophils protect the host by immune surveillance and in situ
elimination of microbes through mechanisms including
phagocytosis.9 In addition, neutrophils are both a target
and a source of various inflammatory mediators and che-
mokines, including matrix metalloproteinases (MMPs).
MMPs are a family of zinc-dependent proteinases that
serve to degrade the extracellular matrix and play impor-
tant roles in the onset of dentin mineralization.10,11 In the
dental pulp, MMPs are released by several cell types, such
as odontoblasts, fibroblasts, and inflammatory cells.12e14
Moreover, these proteolytic enzymes are trapped within
the intact dentin and are released during local demineral-
ization.15,16 Specifically, MMP-2, MMP-3, MMP-9, and MMP-
20 have been reported to be associated with the process
of dentinogenesis.10 It has been observed that considerable
upregulation of MMP-9 may alter the formation of extra-
cellular matrix in odontoblasts.17 In addition, a high level of
MMP-9 has been detected in inflamed dental pulp.18,19
While excessive inflammatory processes may result in
dental tissue breakdown, low-grade inflammation might
promote tissue-regenerative processes, including angiogen-
esis and stem cell migration.20 It has been shown that MTA
induces a proinflammatory and pro-wound healing environ-
ment, and promotes the biomineralization process during
the acute inflammatory stage.21 Neutrophils are key inflam-
matory cells in acute inflammatory responses. However, the
effects of MTA on the functions of neutrophils remain un-
clear. This study attempted to investigate the effects of MTA
on the viability and secretion of inflammatory molecules and
the phagocytic activity of human neutrophils.Materials and methods
Preparation of materials
ProRoot MTA (tooth-colored formula, Dentsply Tulsa Dental,
Johnson City, TN, USA) was used in this study, and another
commonly used filling material, intermediate restorativeas the control material. Thematerials were mixed according
to the manufacturers’ instructions and allowed to set in
Teflon rings (with an inside diameter of 8 mm and a height of
2 mm) at 37C and 100% humidity for 4 or 24 hours.
Preparation of human neutrophils
With the approval of the Institutional Review Board of
Taipei Veterans General Hospital, neutrophils were freshly
purified from venous peripheral blood of healthy human
donors by dextran sedimentation followed by Ficoll density-
gradient centrifugation, as described previously.22 Freshly
isolated neutrophils were directly incubated in Hank’s
balanced salt solution (HBSS)/Ca2þ (2  106 cells/mL) with
MTA or IRM (set on the Teflon rings for 4 or 24 hours) for the
indicated duration at 37C.
Viability of neutrophils
The viability of the treated neutrophils was determined by
detecting the influx of propidium iodide (PI) into neutrophils,
as described previously.23 Neutrophils fixed in 4% para-
formaldehyde served as the controls for dead cells. Neutro-
phils treated with or without MTA or IRM for 30 minutes were
collected, washed, and incubated in HBSS or HBSS containing
4 mg/mL PI (Sigma-Aldrich, St Louis, MO, USA) at 37C for 15
minutes. After being washed twice with HBSS, neutrophils
were passed through a nylon filter (41 mm) (Spectrom,
Spectrum Laboratories, Laguna Hills, CA, USA) and analyzed
by flow cytometry (FACSort, Becton Dickinson, San Jose, CA,
USA) equipped with an argon laser operating at an excitation
wavelength of 488 nm. Data were analyzed using the Cell-
Quest andWinMDI 2.8 software programs (Becton Dickinson).
Fluorescence intensities of 104 cells were measured. The
percentage of viable cells was determined.
Morphological examination by scanning electron
microscopy
For scanning electron microscopy (SEM) observations, neu-
trophils were incubated for 30 minutes with MTA or IRM
(different setting time durations), and control cells incu-
bated with HBSS/Ca2þ were affixed onto glass slides by
cytospinning. Briefly, sampleswerewashed and fixedwith 2%
glutaraldehyde, 4% formaldehyde, and 1% tannic acid (all
from Sigma-Aldrich) in SEM buffer (0.1M sucrose and 0.1M
sodium cacodylate, pH 7.4) at 37C for 30 minutes, and then
at room temperature for 2 hours. Samples were washed in
SEM buffer and dehydrated in a graded ethanol series. After
critical-point drying (Tousimis, Rockville, MD, USA), samples
were mounted on aluminum stubs, coated with gold in a
sputter coater (JFC-1200 fine coater, JEOL, Tokyo, Japan),
and viewed on an SEM (JSM-5300, JEOL).
Release of MMP-9
The gelatinolytic activity of secreted MMP-9 was analyzed by
zymography. Briefly, a 15-mL aliquot of culture supernatant
was loaded onto a 7.5% sodium dodecyl sulfate poly-
acrylamide gel electrophoresis gel containing 0.1% gelatin
Figure 1 Viability of neutrophils was analyzed by PI staining
after incubation with MTA or IRM for 30 minutes. In the histo-
grams, black lines represent the fluorescence intensity of
neutrophils incubated without PI, whereas red areas indicate
the fluorescence intensity of neutrophils incubated with PI. M1
labeled on the histograms represents positive PI staining re-
gions, as determined by the paraformaldehyde-treated control
group. Neutrophils incubated with (A) buffer only, (B) 4%
paraformaldehyde, (C) MTA for 4 hours, (D) MTA for 24 hours,
(E) IRM for 4 hours, and (F) IRM for 24 hours. (G) The abilities of
neutrophils to exclude PI, determined from the results of three
independent experiments, are shown as the mean  SEM.
* P < 0.05 versus the control. IRM Z intermediate restorative
material; MTA Z mineral trioxide aggregate; PI Z propidium
iodide; SEM Z standard error of the mean.
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run at a constant current of 40mA until the blue dye reached
the bottom of the gel. After electrophoresis, the gel was
washed twicewith 50mL 2.5%Triton X-100 (Sigma-Aldrich) at
room temperature for 30 minutes and then incubated in the
developing buffer (50 mM Tris-HCl at pH 8.8, 5 mM CaCl2,
0.02% NaN3, and 0.1% Triton X-100) at 37
C for 16 hours.
Following development, the gel was stained with Coomassie
Blue R-250 for 1 hour and destained by multiple washes of a
destaining solution (45% methanol and 10% acetic acid, v/v).
The gelwas dried between two sheets of cellophane, and the
area of digestion was quantified using a densitometer.
Phagocytosis assay
Fluorescent microspheres (Molecular Probes/Invitrogen,
Carlsbad, CA, USA), 1.0 mm in diameter, were used to inves-
tigate phagocytic processes in neutrophils after treatment
with MTA or IRM. Cells were incubated at 37C for 30 minutes
in the presence and absence of MTA or IRM for the indicated
durations. Treated cells were collected and incubated with
fluorescentmicrospheres (with a cell-to-microsphere ratio of
1:25) at 37C for 1 hour. The reaction was stopped by the
addition of 0.75 mL of ice-cold phosphate-buffered saline
(PBS). Samples were washed twice in cold PBS, and resus-
pended and fixed in 4% formaldehyde in PBS. The fluorescent
intensity, which corresponded directly to the number of
fluorescent beads associated with each neutrophil, was
determined using flow cytometry. The fluorescence in-
tensities of 104 cells were measured. Relative levels of
phagocytic activity compared to control neutrophils that
were incubatedwithHBSS/Ca2þwerecalculated. Inaddition,
samples were centrifuged onto glass slides, counterstained
with 40-6-diamidino-2-phenylindole (DAPI, Sigma, St Louis,
MO, USA) as a nuclear marker, and observed under confocal
microscopy (Fluoview FV1000, Olympus, Tokyo, Japan).
Statistical analysis
Each experiment was repeated independently at least
three times using neutrophils from three different donors to
ensure reproducibility. Statistical analyses were conducted
using a one-way analysis of variance (ANOVA) and Tukey’s
multiple comparison intervals. A P value of <0.05 was
considered significantly different.
Results
Effects of MTA on the viability of neutrophils
Compared to the buffer-treated control group, MTA allowed
to set for either 4 or 24 hours did not affect the cell viability
of neutrophils, indicating that the integrity of plasma
membranes was not affected by exposure to MTA. In
contrast, when neutrophils were incubated with IRM, the
cell viability was reduced to approximately 80% (Fig. 1).
Effects of MTA on the morphology of neutrophils
In the control group, neutrophils displayed a ruffled surface
morphology (Fig. 2A). When incubated with MTA,integration of neutrophils into the complex surface of the
materials was observed (Fig. 2B and 2C). Compared to
control cells, MTA did not alter the size or surface
morphology of neutrophils. However, small amorphous MTA
particles were associated with neutrophils in groups
Figure 2 Scanning electron microscopy of neutrophils incubated on (A) a glass slide, (B) MTA for 4 hours, (C) MTA for 24 hours, (D)
IRM for 4 hours, and (E) IRM for 24 hours. Note that some MTA particles (arrowhead) were of same size as neutrophils (arrow). The
scale is as indicated. IRM Z intermediate restorative material; MTA Z mineral trioxide aggregate.
Effects of MTA on human neutrophils 381exposed to MTA for 24 hours (Fig. 2C). Cell swelling and
disruption of cell membranes were observed in neutrophils
exposed to IRM (Fig. 2D and 2E).
Effects of MTA on MMP-9 expression by neutrophils
During inflammation, MMP-9 is an important inflammatory
mediator released by neutrophils. The amount of MMP-9
released by neutrophils that were treated with MTA or IRM
was determined. As shown in Fig. 3, low levels of MMP-9
production were detected in control cells. Treatment withMTA significantly induced the release of MMP-9 by neutro-
phils, while IRM allowed to set for 4 hours decreased it.
Effects of MTA on the phagocytic activity of
neutrophils
Neutrophils act in concert with monocytes and macro-
phages as phagocytes in the immune system. In the control
group, baseline levels of phagocytic activity were detected
(Fig. 4A). Treatment of neutrophils with MTA increased the
phagocytic activity slightly (Fig. 4B and 4C). When
Figure 3 Effects of MTA on the production of MMP-9 expression as determined by zymography. Two major bands of gelatinase
activity are visible: MMP-9/NGAL (125 kDa) and MMP-9 (92 kDa). Representative results of three independent experiments are
shown. The band intensity was analyzed with a densitometer. Multiples of change relative to the untreated control were calculated
from three independent experiments, and are shown as the mean  SEM. * P < 0.05 versus the control. MMP Z matrix metal-
loproteinase; MTAZ mineral trioxide aggregate; NGAL Z neutrophil gelatinase-associated lipocalin; SEM Z standard error of the
mean.
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decreased (Fig. 4D and 4E). However, the difference did not
reach statistical significance in three independent experi-
ments (Fig. 4F).Discussion
In recent years, many efforts have been made to explore
the regenerative potential of dental pulp. With good
biocompatibility and sealing ability, MTA has been used as a
direct capping material in an attempt to preserve pulp vi-
tality.24 When used in vital pulp therapy, MTA is applied
frequently to injured and inflamed dental pulp. Moreover,
it has been reported that MTA induces neutrophil recruit-
ment through the release of inflammatory mediators from
macrophages and mast cells.25 Therefore, it is of interest to
know how MTA modifies the dental pulp from the initial
inflammatory state to a reparative/regenerative milieu. In
this paper, the effects of MTA on neutrophils, a key in-
flammatory cell type, were determined. Results showed
that MTA did not alter the viability or phagocytic activity of
neutrophils, while it upregulated the release of MMP-9 by
human neutrophils.
The response of neutrophils to biomaterials is associated
with the chemical composition, surface characteristics, and
particle sizes of the materials.26 MTA is a bioactive material
that stimulates biological activities through the release of
various ions such as calcium, silica, bismuth, iron,
aluminum, and magnesium.27 Calcium, as the dominant ionreleased by MTA, regulates the functions of neutrophils,
including chemotaxis, degranulation, and phagocytosis.28,29
In addition, MTA is composed of small particles of various
sizes, ranging from 1.5 mm to 160 mm.30 Ions released from
MTA and the stimulatory effects of MTA particles might
have contributed to the altered functions of neutrophils
observed in this study.
Previous studies demonstrated that after mixing, the
properties of MTA changed over time.5 The compressive
strength and push-out strength reached maximum values
several days after mixing.5 In addition, MTA was found to
release a substantial amount of calcium ions within 14
days, and a significant increase in calcium release was
detected within the first 24 hours.5,31 In this study, the
effects of MTA with different setting times (4 hours or 24
hours) were compared. Results showed that MTA allowed to
set for 4 hours was more effective in inducing the release of
MMP-9 by neutrophils. These results might be attributed to
the fluctuation of calcium release with different setting
times.
In this study, MTA treatment induced MMP-9 production
by neutrophils. This finding is in contrast to the results of
Hashiguchi et al32 who showed that MTA reduced MMP-9
messenger RNA expression by osteoclasts. This discrep-
ancy might be attributed to different treatment conditions.
The expression of MMP-9 by different cell types may pro-
duce diverse biological effects. Mice that lack MMP-9 were
demonstrated to display delayed wound healing and
immature collagen fibrillogenesis.33 In the dental pulp,
MMP-9 production is associated with the onset of dentin
Figure 4 Confocal microscopic images of the phagocytic
activity of neutrophils treated with or without MTA or IRM for
30 minutes. DAPI staining (blue) indicates nuclei, while green
fluorescence indicates phagocytosed microspheres. (A) Control
cells treated with buffer only, and neutrophils incubated with
(B) MTA for 4 hours, (C) MTA for 24 hours, (D) IRM for 4 hours,
and (E) IRM for 24 hours. (F) Relative phagocytic activities
(expressed as multiples of change relative to the control), as
determined by flow cytometry from the results of three inde-
pendent experiments, are shown as the mean  SEM.
DAPI Z 40-6-diamidino-2-phenylindole; IRM Z intermediate
restorative material; MTA Z mineral trioxide aggregate;
SEM Z standard error of the mean.
Effects of MTA on human neutrophils 383mineralization.10 Histological findings revealed that when
MTA was used for vital pulp procedures, healing or bridge
formation was observed at the pulp-exposure interface.6
Those results indicated that MTA might initiate dentin
mineralization through inducing MMP-9 production by
neutrophils.
It was shown that IRM can serve as an interim treatment
option for irreversible pulpitis or as a pulp-capping mate-
rial.1,34 A previous study conducted in our laboratory
demonstrated that eugenol, the main component of IRM,
inhibited the antimicrobial function of neutrophils.23 In this
study, IRM was used in the negative control groups due to an
adverse pulp healing response that was associated with IRM
treatment.35 Results of the present study showed that IRM
decreased the viability of neutrophils possibly due to the
adverse effects of eugenol. In addition, treatment with IRM
decreased the release of MMP-9 by neutrophils, and this
result was in agreement with a study by Santos et al36 who
showed that zinc oxide eugenol cements inhibit MMP
production.
MTA has been shown to be a bioactive material that in-
duces mineralization simultaneously with the acute in-
flammatory response.20 However, little is known about how
inflammatory cells contribute to the biomineralization
process following the treatment with MTA. Results of this
study showed that MTA induced a mild inflammatory
response with transient production of MMP-9 by neutro-
phils. MMP-9 is involved in the onset of dentin mineraliza-
tion.10 These results indicate that MTA might initiate a
reparative mechanism of dental pulp under a controlled
inflammatory response and the induction of MMP-9 by
neutrophils.Acknowledgments
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